Skip to main content
OpenTrials
Completed

NCT Number: NCT07267975

Effectiveness of Oral Iron Therapy in Iron Deficiency Anemia With Daily vs Alternate Day Dosing

Treating iron deficiency anemia in children with daily and alternate day oral iron therapy

Completed

Looking for future studies?

Notify Me

Key information

Age range

1 day–5 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

University of child health science and the children hospital lahore

Lahore, Punjab Province, 54000, Pakistan

About this study

Comparison of effectiveness of oral iron in daily and alternate group in children

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of both genders with ages in the range of 0 -60 months suffering from IDA as per operational definition.

Exclusion criteria

  • Who have already taken treatment for IDA during last 2-months as per history/clinical record.
  • Who have undergone recent blood transfusion during last 12-weeks as per history/clinical record.
  • Children with chronic kidney disease, chronic liver disease, cardiac failure or concomitant malignancy

Treatment and study plan

Ferrous sulphate

Drug

Continuous vs intermittent oral iron therapy to see the difference of Hemoglobin rose in both group

Other names: Daily dosing

Primary outcomes

  1. Rise in hemoglobin level after oral iron

    Time frame: 3 months

    Hemoglobin level change in g/dl

  2. Change in Hemoglobin level

    Time frame: 3month

    Hb rise in g/dl

Secondary outcomes

  1. Rise in ferritin level

    Time frame: 3 month

    Ferritin level change in ng/ml

Sponsors and collaborators

Lead sponsor

University of Child Health Sciences and Children's Hospital, Lahore

Other

Registry information

Official study title

Effectiveness of Intermittent Oral Iron Therapy vs Continuous Oral Iron Therapy in Treating Iron Deficiency Anemia Patients UpTo 5 Year of Age; a Randomized Control Trial

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Dec 5, 2025
Registry last updated
Jun 16, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.